Kevin Latinis
Publications by Year
Research Areas
T-cell and B-cell Immunology, Systemic Lupus Erythematosus Research, CAR-T cell therapy research, Cell death mechanisms and regulation, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study(2012)1,404 cited
- → Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial(2009)1,365 cited
- → Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus(2012)411 cited
- → Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))(2010)346 cited
- → Description of 12 Cases of Nephrogenic Fibrosing Dermopathy and Review of the Literature(2006)262 cited
- → The c-Jun N-Terminal Kinase Cascade Plays a Role in Stress-Induced Apoptosis in Jurkat Cells by Up-Regulating Fas Ligand Expression(1998)235 cited
- → Two NFAT Transcription Factor Binding Sites Participate in the Regulation of CD95 (Fas) Ligand Expression in Activated Human T Cells(1997)217 cited
- → Dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin(2004)216 cited
- → Stress-Induced Fas Ligand Expression in T Cells Is Mediated through a MEK Kinase 1-Regulated Response Element in the Fas Ligand Promoter(1998)190 cited
- → Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events(1997)165 cited